Shenglong Li
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction: Curcumin inhibits colorectal cancer progression by targeting PTBP1 and CDK2-mediated pathways.
Journal: Frontiers in oncology
Published: July 07, 2025
Curcumin inhibits colorectal cancer progression by targeting PTBP1 and CDK2-mediated pathways.
Journal: Frontiers in oncology
Published: January 26, 2025
Effectiveness and Safety of Apatinib Plus Programmed Cell Death Protein 1 Blockades for Patients with Treatment-refractory Metastatic Colorectal Cancer: A Retrospective Exploratory Study.
Journal: Journal of cancer prevention
Published: February 27, 2023
Multi-Omics Characterization of a Glycerolipid Metabolism-Related Gene Enrichment Score in Colon Cancer.
Journal: Frontiers in oncology
Published: February 23, 2022
Correction to: TCONS_00230836 silencing restores stearic acid-induced β cell dysfunction through alleviating endoplasmic reticulum stress rather than apoptosis.
Journal: Genes & nutrition
Published: July 13, 2021
TCONS_00230836 silencing restores stearic acid-induced β cell dysfunction through alleviating endoplasmic reticulum stress rather than apoptosis.
Journal: Genes & nutrition
Published: September 03, 2020
[Retracted] Farnesoid X receptor inhibits proliferation of human colorectal cancer cells via the miR‑135A1/CCNG2 signaling pathway.
Journal: Oncology reports
Published: November 19, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026